Atrium Therapeutics and Bristol-Myers Squibb achieved accelerated approval for Zenbexus therapy following global collaboration on a lead RNA compound.
1 report, 1 independent
Updated Aug 28
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Atrium Therapeutics and Bristol-Myers Squibb achieved accelerated approval for Zenbexus therapy following global collaboration on a lead RNA compound.